The Venture Codex Logo

The Venture Codex

Paramark Ventures

17, Gukjegeumyung-ro 2-gil, Yeongdeungpo-gu, 5F, Suite 520, Seoul, 07327, South Korea

Overview

Paramark Ventures is a venture capital firm focused on early-stage investments. It also invests in businesses with high growth potential in fast-growing markets around the world, with a particular focus on India.

Total investments
12
Lead investments
4
Investments · 12mo
3
Active investors
1

Sector focus

  • Business Development
  • Financial Services
  • Venture Capital
Visit website

Investment portfolio

  • FirstClub

    Participated · Series B · Jun 2026

    Founded in 2024 and headquartered in Bengaluru, FirstClub operates a curated online grocery platform carrying about 4,000 SKUs and emphasizes quality checks on fresh produce and lab-testing of certain staples. The startup has crossed 1 million orders and acquired roughly 170,000 households within a year of launch, operating at an annualized gross market value of about $50 million. Customers place more than four orders per month on average and spend roughly ₹1,200 (about $13) per order. FirstClub operates 21 stores in Bengaluru and recently launched three locations in Hyderabad, and employs about 220 people. The company is focused on expanding geographically and into additional categories including home and kitchen products, gifting, and other household essentials.

  • Kuku FM

    Participated · Series C · Oct 2025

    Founded in 2018, Bengaluru-based Kuku operates two flagship services—Kuku FM for audio shows and Kuku TV for vertically formatted, episodic video stories—both delivered in more than eight Indian languages. The company targets India’s mobile-first audience with low-priced subscriptions (₹199/month, ₹499/quarter, ₹1,499/year) and reports over 10 million paid subscribers, up from 2 million in 2023. Users spend an average of 100 minutes per day on its apps, and more than 90 % of subscribers stay active month-over-month. Across its portfolio, Kuku has amassed 229 million downloads and over US$4 million in consumer spending, with 134 million downloads occurring in 2025 alone. Roughly 10,000 creators—over half from small towns—supply content, collectively earning about ₹400 million (≈US$4.5 million) each month. Kuku augments creator workflows with an in-house GenAI studio that assists in scripting, translation, and thumbnail generation, claiming that 70–80 % of production tasks now leverage generative AI. The firm plans to expand internationally (pilots in the Middle East and U.S.), enhance AI infrastructure, and recruit additional tech and content talent using its new capital.

  • Carta Healthcare

    Participated · Series B · May 2025

    Carta Healthcare provides an AI-powered platform that automates clinical data abstraction and analytics, combining machine learning with deep clinical expertise to extract and structure both structured and unstructured clinical data. Its technology generates actionable insights for health systems and life sciences organizations, streamlining data abstraction processes and reducing labor costs. The company plans to expand its customer footprint—particularly in the life sciences market—and to scale product deployment and operations following its late-2024 acquisition of Realyze Intelligence from UPMC Enterprises. The Realyze Intelligence acquisition added capabilities for rapidly analyzing data and identifying patients who match clinical trials and research studies. Founded in 2017 and headquartered in San Francisco, Carta reports consistent year-over-year growth and says the new capital will support hiring, infrastructure, and expanded market demand. The company’s CFO described Carta as financially healthy and positioned to strengthen its balance sheet and capture market opportunity. Carta Healthcare delivers collection, analysis, and insights into clinical data by providing registry data abstraction, reporting, and analytics to leading health systems. The company combines state-of-the-art technology with a team of experienced clinicians to produce high-quality registry data and associated analytics. By transforming the abstraction process and implementing powerful analytic capabilities, Carta informs data-driven decisions that can improve patient outcomes, reduce data-processing costs, and enable clinicians to spend more time on patient care. The company reports markedly faster data collection, superior data quality, and considerable cost savings for healthcare providers. Carta intends to use the recent funding to scale operations and accelerate product development to make more products accessible to more health systems. The business is focused on enhancing healthcare data processes and analytics to support better patient outcomes and research capabilities. Carta Healthcare provides AI-driven clinical data abstraction technology and services that use natural language processing and machine learning to reduce manual labor in curating trustworthy, actionable datasets. Its platform collects, analyzes, and layers analytic capabilities on clinical data to fuel data-driven healthcare decisions and improve patient care. The company supports the healthcare data registry market by transforming previously manual abstraction processes into automated workflows. Carta plans to use new funding to expand its clinical and technical teams and build new partnerships to make healthcare data more actionable. The company emphasizes making data-driven improvements to care delivery and bringing its solutions to new partners. Carta was founded in 2017 and is headquartered in San Francisco; it announced a recent Series A to accelerate growth.

  • Fourier

    Led · Series A · Apr 2025

    Fourier designs hydrogen electrolyzer modules no larger than two standard server racks, using arrays of small "blade" electrolyzers managed by software. Each module contains about 20 blades fed by a shared pump and powered by lightly modified, commodity data‑center power supplies. The company’s control software monitors individual blades similar to a battery management system, optimizing output and detecting degradation. Fourier has run two lab‑scale pilots that produce about one kilogram of hydrogen per hour with a pharmaceutical manufacturer and a solar energy company. It is deploying two commercial‑scale pilot plants—one at a petrochemical plant in Ohio and another at a Fremont, California aerospace parts company—expected to be operating by June. Fourier targets customers that need 6–20 kilograms per hour (roughly 300 kW to 1 MW of capacity). The company says it can deliver hydrogen for $6–$7 per kilogram (ex‑incentives) versus customer current prices of about $13–$14 per kilogram.

  • ProcMart

    Participated · Series B · Apr 2024

    ProcMart is a New Delhi-based B2B e-commerce and supply chain company that provides one-stop procurement solutions. Its technology platform offers end-to-end support for indirect sourcing, including vendor consolidation, inventory management, digital procurement, expense tracking, and logistics management. The company’s stated vision is to digitize and transform unorganized or manual aspects of the supply chain and B2B commerce through technology. ProcMart will use the new funding for strategic acquisitions. The capital will also support expansion of its distribution network within India and bolster its international operations in Southeast Asia. ProcMart raised $30.0M in a Series B in April 2024. ProcMart is a Noida-based B2B procurement marketplace founded in 2015 by Anish Popli. The company provides supply chain solutions and infrastructure to businesses, including purchase order management, contract administration, master data management, e-catalogue management, and market intelligence. ProcMart is backed by IndiaMART. In November 2022 it raised a $10 million Series A led by Sixth Sense Ventures. In its latest financing ProcMart raised INR 25 crore (USD 3 million) via issuance of 5,933 pre-Series B CCPS at an issue price of INR 42,127 each to Sixth Sense Ventures India. The round values the company at INR 275 crore and has made Sixth Sense the largest external shareholder with a 30% stake, while founder and CEO Anish Popli retains 41.76%.

Team